文献速递肺外科

下叶上段与基底段I期非小细胞肺癌的临床预后比较

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2017-10-21

回顾性分析134例临床I期、影像学实性为主的下叶非小细胞肺癌患者,比较上段(60例)与基底段(74例)肿瘤的预后差异。上段组5年总生存率和无复发生存率均显著低于基底段组,上段肿瘤是预后不良的独立因素。

要点

  • 下叶上段I期NSCLC预后较基底段差。
  • 上段肿瘤是总生存和无复发生存独立不良因素。
  • 上段组纵隔淋巴结转移倾向更高。

核心结论

  • 下叶上段肿瘤是临床I期非小细胞肺癌预后不良因素,生存劣于基底段肿瘤。

主要发现

  • 上段组5年总生存率62.6%对基底段组89.9%(p=0.0072),5年无复发生存率54.4%对75.7%(p=0.032)。
  • 多变量Cox回归显示上段肿瘤是总生存不良的独立因素(HR 3.33,95%CI 1.22-13.5,p=0.010)。
  • 上段肿瘤是无复发生存不良的独立因素(HR 2.90,95%CI 1.20-7.00,p=0.008)。
  • 上段组病理纵隔淋巴结转移比例15.0%对基底段组5.4%(p=0.080)。

临床怎么用

  • 对下叶上段临床I期NSCLC应更重视纵隔淋巴结评估和术后随访。

局限性

  • 回顾性单中心研究,样本量有限,纵隔淋巴结转移差异未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite its extensive size, variations in the clinicopathologic features of tumors in the lower lobe have been little studied. The present study investigated the prognostic differences in tumors originating from the superior and basal segments of the lower lobe in patients with non-small cell lung cancer. METHODS: Data of 134 patients who underwent lobectomy or segmentectomy with systematic nodal dissection for clinical stage I, radiologically solid-dominant, non-small cell lung cancer in the superior segment (n = 60) or basal segment (n = 74) between April 2007 and December 2015 were retrospectively reviewed. Factors affecting survival were assessed by the Kaplan-Meier method and Cox regression analyses. RESULTS: Prognosis in the superior segment group was worse than that in the basal segment group (5-year overall survival rates 62.6% versus 89.9%, p = 0.0072; and 5-year recurrence-free survival rates 54.4% versus 75.7%, p = 0.032). In multivariable Cox regression analysis, a superior segment tumor was an independent factor for poor overall survival (hazard ratio 3.33, 95% confidence interval: 1.22 to 13.5, p = 0.010) and recurrence-free survival (hazard ratio 2.90, 95% confidence interval: 1.20 to 7.00, p = 0.008). The superior segment group tended to have more pathologic mediastinal lymph node metastases than the basal segment group (15.0% versus 5.4%, p = 0.080). CONCLUSIONS: Tumor location was a prognostic factor for clinical stage I non-small cell lung cancer in the lower lobe. Patients with superior segment tumors had worse prognosis than patients with basal segment tumors, with more metastases in mediastinal lymph nodes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Handa Y, Tsutani Y, Tsubokawa N, et al. Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017. PMID: 29033013. doi:10.1016/j.athoracsur.2017.06.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。